Application of micronized acellular dermal matrix in primary premature ejaculation: a preliminary study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039370

Enrollment

Unknown

Registered

2020-10-24

Start date

2019-08-01

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature ejaculation

Interventions

Case series:inject the ADM

Eligibility

Sex/Gender

Male

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-45 years; 2. Having regular sexual partners in the past 6 months; 3. Patients with IIEF-5 score greater than 26; 4. Patients with no recent history of alcohol drinking and oral medication; 5. Patients who voluntarily participated in this experiment; 6. Patients whose SSRI or antidepressants are ineffective or intolerable.

Exclusion criteria

Exclusion criteria: 1. Patients with bleeding disorder; 2. Penile scar formation and other conditions, such as the application of psychological drugs.

Design outcomes

Primary

Measure	Time frame
intravaginal ejaculation latency time;premature ejaculation diagnostic tool;	—

Countries

China

Contacts

Public ContactYuan Mingzhen

Shandong University

yuanmingzhen2005@126.com+86 15053155899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026